Evaluation of Type II Killed BVD Vaccine in the Face of Type II BVD Challenge

Authors

  • Donna M. Gatewood Diamond Animal Health, 2538 SE 43rd Street, Des Moines, Iowa 50317
  • W. Charles Ohnesorge Diamond Animal Health, 2538 SE 43rd Street, Des Moines, Iowa 50317
  • Carol A. Spillers Diamond Animal Health, 2538 SE 43rd Street, Des Moines, Iowa 50317
  • Benjamin P. All Diamond Animal Health, 2538 SE 43rd Street, Des Moines, Iowa 50317

DOI:

https://doi.org/10.21423/aabppro19965966

Keywords:

Type II BVD, MLV, management situation, modified live vaccine, killed vaccine, Type I BVD

Abstract

Type II BVD continues to be a concern for cattle producers. Type I MLV BVD vaccines reportedly provide adequate protection against disease caused by Type II BVD. However, MLV vaccines cannot be used in all management situations. This study was designed to test the efficacy of an experimental killed Type II BVD vaccine. In addition, the study compared results with efficacy of modified live and killed Type I BVD vaccines, as well as with efficacy of a killed Type II/MLV Type I combination.

Downloads

Published

1996-09-12

Issue

Section

Research Summaries 1